Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for ...

Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:40 Hrs [IST] Akums Drugs & Pharmaceutical ...

A recent study published in the journal of BMC Diabetology & Metabolic Syndrome revealed a reciprocal causal relationship ...

Glaucoma is a silent disease that leads to blindness. However, 90% of blindness cases caused by glaucoma could be prevented ...

Glaucoma, a chronic eye disease, gradually damages the optic nerve, without showing any symptoms, but slowly leading to vision loss and even blindness, if left untreated. Nearly 90% of glaucoma cases ...

Glaucoma may have no cure, but with occasional checkups, a healthy lifestyle, and good eye care, its progression can be ...

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

ROCKLATAN/ROCLANDA holds significant market potential for treating open-angle glaucoma (OAG) and ocular hypertension ... High ...

Glaucoma is an eye condition that damages the optic nerve, leading to irreversible vision loss. Glaucoma affects ...

The 9 recipients receive $55,000 in seed money for collaborative projects that target one or more of the foundation’s ...

For people at high risk of glaucoma, Medicare Part B pays for annual preventive screening. Glaucoma testing can include a dilated eye exam, direct ophthalmoscopic examination, and more.